Emergency Obstetric and Neonatal Care: The EmONC Trial

Sponsor
NICHD Global Network for Women's and Children's Health (Other)
Overall Status
Completed
CT.gov ID
NCT01073488
Collaborator
(none)
267,181
7
2
34
38168.7
1123.6

Study Details

Study Description

Brief Summary

The objective of this cluster randomized controlled trial is to reduce maternal and neonatal mortality by increasing access to and improving the quality of obstetric and neonatal care for pregnant women in study clusters. It is hypothesized that a 25% reduction in >28 week or

1000 gram stillbirth and 7-day neonatal mortality will be achieved in the intervention clusters by a multifaceted Emergency Obstetric Neonatal Care (EmONC) package that will be introduced by an EmONC team.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Community Mobilization, HBLSS and facility improvement
N/A

Detailed Description

Maternal death, stillbirth, early neonatal death, and obstetric fistula are among the most devastating adverse outcomes of pregnancy. Existing interventions could avert the majority of maternal and neonatal deaths; however, those women at greatest risk are least likely to have access to interventions delivered through the formal health care system. In many developing countries, most deliveries in rural areas and a significant number in urban areas are conducted at home without skilled attendance, circumstances which pose a high risk for both mothers and their neonates. The EmONC trial is designed to evaluate a comprehensive intervention encompassing community mobilization to establish and sustain mechanisms of transport and payment and to drive client-oriented emergency obstetrical and neonatal care. The intervention includes teaching recognition of prolonged labor, infection, preeclampsia and hemorrhage, and the use of appropriate stabilization methods by all community birth attendants. In addition, poor access to quality emergency obstetric and neonatal care in a sustainable manner will be addressed. To evaluate the effectiveness of this approach, a cluster-randomized trial is required to assess whether Cluster EmONC teams can work with the community and health care system to reduce adverse pregnancy outcomes in diverse settings where the majority of deliveries occur at home or at a health clinic with few or no available EmONC interventions. To accomplish the intervention, a train-the-trainer approach will be used. Master trainers will facilitate central and regional training sessions for Country trainers organized around the areas of community mobilization; birth attendant skills; and EmONC referral facility improvements. The Country trainers will then support training and related activities in the intervention clusters, predominantly focusing on these three areas. The study population includes pregnant women (and their neonates) living and delivering in the 108 study clusters. The study clusters are largely rural, geographically distinct communities, each of which have approximately 300 annual deliveries. The women will be enrolled at or after 20 weeks gestation and followed to 42 days post delivery. The total duration of the trial will be 24 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
267181 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Evaluation of an Emergency Obstetric and Neonatal Care (EmONC) Intervention Package to Reduce Adverse Pregnancy Outcomes in Low Resource Settings (The EmONC Trial)
Study Start Date :
Dec 1, 2008
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Oct 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: EMONC: Community mobilization, HBLSS and Facility Improvement

The intervention group received training in community mobilization activities, Home Based Life Saving Skills (HBLSS) and facility improvement.

Behavioral: Community Mobilization, HBLSS and facility improvement
Mobilization of the community, with special emphasis on pregnant women and their families, to identify resources and solutions to improve maternal and neonatal mortality, home-based life savings skills (HBLSS) for community birth attendants and facility improvement activities.
Other Names:
  • CM
  • No Intervention: Control

    The control group did not receive an intervention, but collected outcome data through a baseline maternal/newborn birth registry.

    Outcome Measures

    Primary Outcome Measures

    1. Composite of either >28 week / >1000 gram stillbirth or 7 day neonatal mortality rate [7 days post delivery]

    Secondary Outcome Measures

    1. Maternal mortality rate [42 days post delivery]

    2. Maternal morbidity rates [42 days post delivery]

    3. Stillbirth rate [Delivery]

    4. 7-day neonatal mortality rate [7 days post delivery]

    5. 28-day neonatal mortality rate [28 days post delivery]

    6. Rates of mothers transported to a referral hospital. [42 days post delivery]

    7. Rates of neonates/infants transported to a referral hospital [42 days post delivery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Pregnant women living in and/or delivering within the study cluster

    2. Consent provided

    Exclusion Criteria: Eligible pregnant women who do not consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Buenos Aires Buenos Aires Argentina
    2 IMSALUD / San Carlos University Guatemala City Guatemala
    3 Jawaharlal Nehru Medical College Belgaum India
    4 Indira Gandhi Government Medical College Nagpur India
    5 Moi University School of Medicine Eldoret Kenya
    6 The Aga Khan University Karachi Pakistan
    7 University Teaching Hospital Lusaka Zambia

    Sponsors and Collaborators

    • NICHD Global Network for Women's and Children's Health

    Investigators

    • Principal Investigator: Robert Goldenberg, MD, Drexel University College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    NICHD Global Network for Women's and Children's Health
    ClinicalTrials.gov Identifier:
    NCT01073488
    Other Study ID Numbers:
    • GN EmONC
    First Posted:
    Feb 23, 2010
    Last Update Posted:
    Nov 18, 2013
    Last Verified:
    Nov 1, 2013

    Study Results

    No Results Posted as of Nov 18, 2013